Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line

Molecular Therapy

Volumn 10, Issue 3, 2004, Pages 562-573

  Virella Lowell, Isabel ^a   Herlihy, John David ^a   Liu, Barry ^a,b   Lopez, Cecilia ^a,b   Cruz, Pedro ^a,b   Muller, Chris ^a,b   Baker, Henry V ^a,b   Flotte, Terence R ^a,b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Adeno associated virus (AAV); Cystic fibrosis (CF); Expression profiling; Functional genomics

Indexed keywords

INTERLEUKIN 10; PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSFECTION; NONHUMAN; PHENOTYPE; PROTEIN GLYCOSYLATION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UPREGULATION;

ANIMALS; BRONCHI; CELL LINE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-10; MUTATION; PSEUDOMONAS AERUGINOSA; RESPIRATORY MUCOSA; TRANSFECTION;

ADENO-ASSOCIATED VIRUS; BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 4444346481     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.06.215     Document Type: Article

References (44)

1. Riordan J.R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA Science 245 1989 1066-1073 [Published erratum appears in Science (1989) 245: 1437]
2. - channels by protein kinase A corrected by insertion of CFTR Nature 358 1992 581-584
3. Lobeck C.C. Cystic fibrosis The Metabolic and Molecular Bases of Inherited Disease 1995 McGraw-Hill New York
4. DiMango E. Ratner A.J. Bryan R. Tabibi S. Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells J. Clin. Invest. 101 1998 2598-2605
5. Moore K.W. de Waal Malefyt R. Coffman R.L. O'Garra A. Interleukin-10 and the interleukin-10 receptor Annu. Rev. Immunol. 19 2001 683-765
6. Yoshidome H. Kato A. Edwards M.J. Lentsch A.B. Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion Am. J. Physiol. 277 5 Pt 1 1999 L919-L923
7. DiMango E. Zar H.J. Bryan R. Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8 J. Clin. Invest. 96 1995 2204-2210
8. Oermann C.M. Sockrider M.M. Konstan M.W. The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes Chest 115 1999 1053-1058
9. Balfour-Lynn I.M. Dinwiddie R. Role of corticosteroids in cystic fibrosis lung disease J. R. Soc. Med. 89 Suppl. 27 1996 8-13
10. Balfour-Lynn I.M. Klein N.J. Dinwiddie R. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis Arch. Dis. Child. 77 1997 124-130
11. Balfour-Lynn I.M. Dezateux C. Corticosteroids and ibuprofen in cystic fibrosis Thorax 54 1999 657
12. Nikolaizik W.H. Schoni M.H. Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis J. Pediatr. 128 1996 271-274
13. van Haren E.H. Lammers J.W. Festen J. Heijerman H.G. Groot C.A. van Herwaarden C.L. The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis Respir. Med. 89 1995 209-214
14. Doring G. et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus Eur. Respir. J. 16 2000 749-767
15. Doring G. Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis Pediatr. Pulmonol. 28 1999 363-375
16. Doring G. Anti-inflammatory therapy Pediatr. Pulmonol. Suppl. 16 1997 271-272
17. Konstan M.W. Hoppel C.L. Chai B.L. Davis P.B. Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects J. Pediatr. 118 1991 956-964
18. Konstan M.W. Byard P.J. Hoppel C.L. Davis P.B. Effect of high-dose ibuprofen in patients with cystic fibrosis N. Engl. J. Med. 332 1995 848-854
19. Konstan M.W. Treatment of airway inflammation in cystic fibrosis Curr. Opin. Pulm. Med. 2 1996 452-456
20. Konstan M.W. Therapies aimed at airway inflammation in cystic fibrosis Clin. Chest Med. 19 1998 505-513 vi
21. Sermet-Gaudelus I. et al. Interest of colchicine for the treatment of cystic fibrosis patients: preliminary report Mediators Inflammation 8 1999 13-15 vi
22. Oishi K. et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases Infect. Immun. 62 1994 4145-4152
23. Fiedler M.A. Wernke-Dollries K. Stark J.M. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132 Am. J. Respir. Cell Mol. Biol. 19 1998 259-268
24. Griesenbach U. et al. Anti-inflammatory gene therapy directed at the airway epithelium Gene Ther. 7 2000 306-313
25. Hansen G. Schuster A. Zubrod C. Wahn V. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum Respiration 62 1995 117-124
26. McElvaney N.G. et al. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis Lancet 337 1991 392-394
27. Sawa T. Corry D.B. Gropper M.A. Ohara M. Kurahashi K. Wiener-Kronish J.P. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia J. Immunol. 159 1997 2858-2866
28. Chmiel J.F. et al. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice Am. J. Respir. Crit. Care Med. 160 1999 2040-2047
29. Heeckeren A. Walenga R. Konstan M.W. Bonfield T. Davis P.B. Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa J. Clin. Invest. 100 1997 2810-2815
30. Zeitlin P.L. et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection Am. J. Respir. Cell Mol. Biol. 4 1991 313-319
31. Flotte T.R. Solow R. Owens R.A. Afione S. Zeitlin P.L. Carter B.J. Gene expression from adeno-associated virus vectors in airway epithelial cells Am. J. Respir. Cell Mol. Biol. 7 1992 349-356
32. Flotte T.R. et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter J. Biol. Chem. 268 1993 3781-3790
33. Schwiebert E.M. Flotte T. Cutting G.R. Guggino W.B. Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents Am. J. Physiol. 266 5 Pt 1 1994 C1464-1477
34. Imundo L. Barasch J. Prince A. Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface Proc. Natl. Acad. Sci. USA 92 1995 3019-3023 [Published erratum appears in Proc. Natl. Acad. Sci. USA (1995) 92: 11322]
35. Eidelman O. et al. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway Mol. Med. 7 2001 523-534
36. Guay-Broder C. et al. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation Biochemistry 34 1995 9079-9087
37. Casavola V. Turner R.J. Guay-Broder C. Jacobson K.A. Eidelman O. Pollard H.B. CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells Am. J. Physiol. 269 1 Pt 1 1995 C226-C233
38. Venkatakrishnan A. et al. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells Am. J. Respir. Cell Mol. Biol. 23 2000 396-403
39. Goudy K. et al. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice Proc. Natl. Acad. Sci. USA 98 2001 13913-13918
40. Ichikawa J.K. et al. Interaction of Pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs Proc. Natl. Acad. Sci. USA 97 2000 9659-9664
41. Lory S. Ichikawa J.K. Pseudomonas-epithelial cell interactions dissected with DNA microarrays Chest 121 3 Suppl 2002 36S-39S
42. Srivastava M. Eidelman O. Pollard H.B. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis Mol. Med. 5 1999 753-767
43. Visner G.A. Dougall W.C. Wilson J.M. Burr I.A. Nick H.S. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor: role in the acute inflammatory response J. Biol. Chem. 265 1990 2856-2864
44. Livak K.J. Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2( and minus;Delta Delta C(T)) method Methods 25 2001 402-408